FDA approves Tamarack Biotics’ non-thermal UV light milk treatment

USA – The USA Food and Drug Administration (FDA) has approved Tamarack Biotics’ UV light-based milk treatment process, enhancing a new generation of dairy products that retain the full bioactive benefits of raw milk by not using heat.

The FDA’s determination confirms that Tamarack’s method meets the official efficacy criteria for pasteurization, allowing for its initial use in powdered dairy ingredients such as whey protein concentrate, milk protein concentrate, and immune-supporting compounds like lactoferrin.

Tamarack Biotics’ TruActive process eliminates harmful pathogens while preserving the enzymes, proteins, and immunity-supporting compounds that traditional heat-based pasteurisation often destroys.

Tamarack highlighted that the result is a scientifically verified, safe, raw milk equivalent, a first in the dairy industry and an exciting development for the growing public demand for raw and minimally processed foods.

“Safe treatment of milk hasn’t fundamentally changed in over 150 years. We’ve created a solution that brings raw milk safety into the 21st century, without sacrificing what makes milk truly nutritious. Our UV process achieves a greater level of safety than thermal pasteurization, which is truly remarkable, said Bob Comstock, CEO of Tamarack Biotics.

FDA greenlights first human milk-based fortifier

Recently, THE FDA approved a human milk-based nutritional product explicitly designed for full-term infants.

Reported by Prolacta Bioscience Hospital, a leading supplier of 100% human milk-based supplements, the newly approved Surgifort human milk fortifier is aimed at aiding term infants recovering from gastroschisis surgery.

Gastroschisis, a birth defect where an infant’s intestines protrude through the abdominal wall, affects fewer than 2,400 babies annually in the USA and requires surgical intervention followed by enhanced nutritional support.

Surgifort fortifier, a pasteurized product derived from donated human milk, is formulated to deliver critical protein, calories, and minerals essential for growth. 

When mixed with term human milk and given in proper amounts, it aligns with the nutritional guidelines set by the National Academy of Medicine. 

According to Prolacta, the fortifier addresses the increased macronutrient demands of infants post-surgery, helping them recover more effectively. 

Research shared by the company shows that infants on an Exclusive Human Milk Diet, including Surgifort, experience quicker weight gain and reach full feeding volumes faster than those on other diets, a vital factor in their healing process.

Subscribe to receive our email newsletters with the latest news and insights from Africa, the Middle East and around the world. SUBSCRIBE HERE